Company profile

Iovance Biotherapeutics

Observed names Iovance

Website 14 open roles

Biotech

Product company

Founded

2007

Employees

Enterprise

Headquarters

Not available

Open roles

14 open roles

About

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. The company is pioneering a transformational approach to treating cancer by harnessing the human immune system to recognize and attack cancer cells, with a TIL platform showing promising clinical data across multiple solid tumors.

Company details

OwnershipPublic

Business models

B2B

B2C

24 observationsLast observed Aug 21, 2026

Links

Websiteiovance.com

Open roles

14 open roles

Director, US Scientific Marketing – Melanoma

Aug 20, 2026

Iovance Biotherapeutics

EligibilityRemoteUnited States only

Languages

Scientific marketingMedical educationMedical education (MedEd)Peer-to-peer (P2P) program developmentSpeaker program developmentReal-world evidence (RWE) / HEORStrategic planningAnalytical skills

$250k–$265k/yr

Associate Director, Regulatory Affairs

Aug 20, 2026

Iovance Biotherapeutics

EligibilityRemoteUnited States only

Languages

$175k–$190k/yr

Director, Clinical Science

Aug 12, 2026

Iovance Biotherapeutics

EligibilityRemoteUnited States only

Languages

Microsoft Office Suite

$175k–$225k/yr

View all 14 roles